Giant cell myocarditis causing refractory ventricular tachycardia in a pediatric patient
Apurva Panchal1, Obehioye Okojie1, Brittany Slagle1
1Department of Pediatrics University of Kansas Medical Center Kansas City Kansas.
Clinical Case Reports
|April 12, 2018
Insights
Giant cell myocarditis is a rare but serious heart condition that can cause dangerous ventricular arrhythmias in children. Diagnosis requires an endomyocardial biopsy to confirm the presence of giant cells in the heart muscle.
Area of Science:
- Cardiology
- Pediatric Cardiology
- Pathology
Background:
- Refractory ventricular arrhythmias in pediatric patients present a significant clinical challenge.
- Giant cell myocarditis is an uncommon but potentially life-threatening cardiac condition.
Observation:
- This abstract highlights the critical need to consider giant cell myocarditis in pediatric cases of persistent ventricular arrhythmias.
- The diagnostic pathway for this condition is emphasized.
Findings:
- Giant cell myocarditis should be included in the differential diagnosis for pediatric patients experiencing refractory ventricular arrhythmias.
- An endomyocardial biopsy is the definitive method for confirming the diagnosis.
Implications:
- Early consideration and diagnostic confirmation of giant cell myocarditis can lead to timely and appropriate management strategies.
- This underscores the importance of invasive diagnostic procedures in select pediatric cardiac cases.
- Improved diagnostic yield for giant cell myocarditis may enhance patient outcomes.
Abstract:
Giant cell myocarditis should be considered in all pediatric patients with refractory ventricular arrhythmia. Endomyocardial biopsy should be obtained to confirm the diagnosis of giant cell myocarditis.
Keywords:
Endomyocardial biopsygiant cell myocarditisheart transplantationpediatric patientsventricular tachycardiaMore Related Videos
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
277
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
277
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
334
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
334
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
245
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
245
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
310
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
310
01:21Myocarditis I: Introduction
443
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
443
01:22Myocarditis IV: Nursing Management
269
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
269